Indeed, it has been shown in cell culture in vitro and in brain in vivo that NMO-IgG activates complement, leading to astrocyte cytotoxicity, which accounts for the loss of AQP4, GFAP and complement deposition in NMO lesions [20], [35]. Here, GFAP is linked to neuromyelitis optica.